| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/19/2001 | WO2000071104A3 Use of bisphosphonic acids for treating angiogenesis |
| 07/19/2001 | WO2000064485A9 Specifically targeted catalytic antagonists and uses thereof |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | US20010008944 Reacting 3-alkoxy/hydroxy-2-halo-cycloheptenone derivative with alkylamidine hydrochloride to form cycloheptimidazole-8-one compound |
| 07/19/2001 | US20010008941 Treating osteoporosis; having no endometrial hyperplasia activity nor breast tumor proliferation activity |
| 07/19/2001 | US20010008903 Dioxinoindole and thienobenzodioxin compounds which are ht3 receptor antagonists and are used to treat central nervous system disorders |
| 07/19/2001 | US20010008901 Nitrile derivatives that inhibit cathepsin K |
| 07/19/2001 | DE10001879A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke |
| 07/19/2001 | DE10001166A1 Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung Fused pyrrole compounds, pharmaceutical compositions containing them and their use |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397283A1 New imidazole derivatives |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396962A1 Benzosulfones and related compositions and methods |
| 07/19/2001 | CA2396413A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof |
| 07/19/2001 | CA2396330A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2396235A1 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | CA2396157A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2395567A1 Novel treatment for eye disease |
| 07/19/2001 | CA2366621A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/18/2001 | EP1116487A2 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115845A2 Fibrils |
| 07/18/2001 | EP1115741A2 Stereoselective process for enalapril |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115733A1 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/18/2001 | EP1115721A1 Pyrimidone derivatives |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115718A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115702A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115694A1 Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | EP1115481A1 Compound storage |
| 07/18/2001 | EP1115421A2 Use of glp-1 or analogs in treatment of stroke |
| 07/18/2001 | EP1115397A1 Method of mitigating the adverse effects of interleukin-2 |
| 07/18/2001 | EP1115396A1 Pharmaceutically active compounds and methods of use thereof |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP0823903B1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1304416A Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and use |
| 07/18/2001 | CN1304408A N-benzodioxanylmethyl-piperidyl-methylamine compounds having effinity for 5-HT receptors |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1304322A Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1304307A 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 07/18/2001 | CN1303858A Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases |
| 07/18/2001 | CN1303700A Medicine for curing cerebrovascular disease |
| 07/18/2001 | CN1303688A Pressure-reducing oral liquor |
| 07/18/2001 | CN1068592C Imidazole derivatives having affinity for alpha 2 receptors activity |
| 07/18/2001 | CN1068587C Ortho-substituted benzoic acid derivatives |
| 07/18/2001 | CN1068586C Crystalline polymorphic form of (S.S.S)-N-(1-[2-carboxy-3-(N2-mesyllysylamino)propyl]-1-cyclopenlylcarbonyl) throsine |
| 07/18/2001 | CN1068520C Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 07/18/2001 | CN1068517C Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease |
| 07/18/2001 | CA2332169A1 Treatments for obesity and methods for identifiying compounds useful for treating obesity |
| 07/18/2001 | CA2296997A1 Treatment of congestive heart failure |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262233 Tissue factor pathway inhibitor-3 |
| 07/17/2001 | US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262102 Eprosartan monohydrate |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy |
| 07/17/2001 | US6262092 Mutual salt of amlodipine and atorvastatin |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262088 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 07/17/2001 | US6262087 Indane or dihydroindole derivatives |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262062 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261598 Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein |
| 07/17/2001 | CA2065040C Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |